Skip to main content
Premium Trial:

Request an Annual Quote

Exagen Records Sharp Increase in Revenues for First Nine Months of 2014

NEW YORK (GenomeWeb) – Exagen Diagnostics said in a regulatory document that its revenues through the first nine months of 2014 grew almost four-fold year over year.

The company, which filed in September with the US Securities and Exchange Commission for a $69 million initial public offering, said in an amended Form S-1 on Friday that it had $7.4 million in revenues for the nine months through Sept. 30, up from $2.0 million in the comparable period a year ago.

It had a net loss of $12.4 million in the first nine months of 2014, up from a net loss of $7.0 million in the year-ago period.

Exagen said it had $7.1 million in cash and cash equivalents as of Sept. 30.

The Vista, Calif.-based firm is developing diagnostics for autoimmune rheumatic diseases. Its lead test is Avise SLE+CT for diagnosing patients with autoimmune rheumatic diseases, such as system lupus erythematosus (SLE), rheumatoid arthritis, Sjögren's syndrome, scleroderma, and disorders that mimic autoimmune rheumatic diseases. Based on a blood draw, the test allows physicians to rule in or rule out SLE and provides information about the presence of other autoimmune rheumatic diseases.

The Scan

Study Follows Consequences of Early Confirmatory Trials for Accelerated Approval Indications

Time to traditional approval or withdrawal was shorter when confirmatory trials started prior to accelerated approval, though overall regulatory outcomes remained similar, a JAMA study finds.

Sequencing Study Leads to Vaccine Target in Bacteria Behind Neonatal Meningitis

Researchers eBioMedicine track down potential vaccine targets with transposon sequencing on mutant bacteria causing neonatal meningitis in mouse models of the disease.

Multiple Myeloma Progression Influenced by Immune Microenvironment Expression

Researchers in NPJ Genomic Medicine compare RNA sequencing profiles of 102,207 individual cells in bone marrow samples from 18 individuals with rapid or non-progressing multiple myeloma.

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.